During the seven day period, the Regulation D market contracted at a slightly faster pace both in terms of funds raised by issuers and number of transactions. The amount of money raised was propped by a small number of companies that raised unusually big financing rounds. Additionally, the activity of the VC & SMB market contracted with a fundraising and activity growth rates that underperformed the overall Regulation D market.
VC and operating companies captured 3.2% of the overall pool of money raised via Regulation D, however they accounted for 35% of Form D filers during the past seven days. Issuers collected 68 cents for each dollar offered, representing a decline of 14% for the period. Following a more stable trend, compliance scores on average reached 94.
45 issuers, or 31%, checked ” Other “ as industry when filing with the SEC. XDATA through its curating process narrowed it down to 26 or 6.9%.
During the past seven days, the Regulation D market expanded at a faster pace in terms of transactions while the pool of money raised grew at milder rate. Furthermore, the activity of the VC & SMB market expanded at a slower pace than the overall Regulation D market, though fundraising growth outpaced it.
Last week, the number of fundraising transactions increased by 15% to 223. Reg D issuers were significantly more bullish than before and offered the market $2.34 billion worth of securities, an improvement of 91%. Charting a similar path, investors purchased much more, subscriptions rocketed 122% to $1.89 billion.
“The average financing round gathered by seed stage companies was stable and reached $1 million. Investors increased their subscriptions to $58 million via 43 closed and partially closed placements. Seed stage Reg D offerings accounted for 23% of the issuances and 6.9% of the money raised. The average compliance score for companies falling into this development stage bracket stood at 96.
Analysis: the activity of seed stage issuers expanded, however their fundraising growth was below the overall SMB market benchmark.”
“Biotech companies sold 51% of their planned issuances, a steep decline from 114%. Slightly smaller private placement transactions typified the period. On average, they eased by $158,804 to $1 million. Investors subscribed to $24 million worth of securities (up 101%) via 18 Reg D offerings (up 125%). Biotech companies were behind 2.8% of the money raised during the seven days ending on June 12, and were a negligible market participant in terms of amount raised. Issuers saw their compliance score drop to 92 from 99.”
“New York-headquartered companies funneled 8.7% of the pool of money available to VC-backed and operating companies and accounted for 7.5% of the activity. Financing targets set by issuers were 95% met. They captured 13 cents more for each dollar offered. Reg D issuers on average collected more money per security issuance than before. The average financing size went up by $1 million to $5 million. 15 private placement transactions were launched, eventually gathering $72 million (up from $51 million) via 14 fundraising events. Companies saw their compliance score go down to 90 from 95.
Analysis: the activity in the State of New York expanded, however the growth of funds raised outperformed the market.”
…and so much more.
“The activity of the VC & SMB market contracted with a growth rate that underperformed the overall Regulation D market.
VC and operating companies captured 13% of the overall funds raised via Regulation D, however they represented 34% of Form D filers during the seven days ending on June 5. Financial backers acquired 75 cents for each dollar offered, representing a decline of 22% for the period. Following a more stable trend, compliance scores on average reached 95.
During the week, the number of closed and partially closed financing rounds decreased by 31% to 159. Reg D issuers were much less bullish than before and offered the market $936 million worth of securities, a decline of 66%. Following a similar pattern, investors subscribed to much less, subscriptions shrank 74% to $698 million.”
“The activity of the VC & SMB market expanded, both fundraising and the activity grew at a faster pace than the overall Reg D market.
VC and operating companies captured 19% of the overall pool of money raised via Regulation D, yet they represented 46% of Form D filers during the seven days ending on May 27. Issuers fetched 97 cents for each dollar offered, representing an improvement of 52% for the period. Following a more stable trend, compliance scores on average reached 94.
During the week, the number of fundraising transactions increased by 8.7% to 225. Companies were much more bullish than before and offered the market $2.73 billion worth of securities, an improvement of 77%. Mirroring a similar path, investors acquired much more, subscriptions grew 282% to $2.64 billion.”
During the seven day period, the Regulation D market contracted at a slightly faster pace in terms of transactions while the pool of money raised shrank at an a milder clip. The activity of the VC & SMB market contracted in line with the overall Regulation D market trend though fundraising growth outpaced the overall Regulation D market.
Download the complete weekly report below
I am delighted to announce the release of a series of activity reports focusing on the VC & SMB financing market as well as 24h turnaround consulting service for clients who need custom activity reports based on issuers’ location, industry, custom time-frame and any other combination of attributes.
The reports showcase XDATA’s normalized and curated content set based on Regulation D. They also leverage Yseop‘s natural language generation technology that enables us to provide unmatched market analytics while allowing us to continue to focus on what we do best: collect, normalize, curate, contextualize and provide a second life to a source of information that has been abused by data miners and that has been traditionally poorly leveraged by data providers.
While our Q1 2016 investment amount is right on the money with the NVCA’s MoneyTree Report ($11.94Bln vs. $12.1Bln), the most important is that our number of transactions is not (2.2K vs 1K) because our research process actually offers a more complete and unbiased view of the private SMB market than venture capital data sets that are based on unregulated information such as press release and therefore, fraught with inaccuracies. At the very least (and most importantly), we provide an alternative and a novel and fresh perspective to investment professionals and market participants.
CrunchBase is a great tool but if you think any data provider covers it all (us included), think again. Last week 85% of the deals we reported were not in CrunchBase and are probably missing in most databases. Perhaps it is time to add XDATA as part of your market monitoring regimen, 14 days free trials are available here.
Contact us to get the complete list of last week’s disclosures for your audit at info@XDATA.co.
First installment of a weekly report on private placements filed with the SEC by operating companies. XDATA is the premium source for curated VC financing and private placements initiated by private companies on the US market under Regulation D. Our deal synopsis offer a comprehensive business overview along with prior financing analysis.
The cannabis industry initiated 23 private placements during Q3 14 offering $114* million worth of securities to qualified and accredited investors as well as QIBs. The companies disclosed having raised at the time of filing $35.4 million or roughly 1/3rd of their placement. XDATA broadly classified companies in categories, namely producers and associated activity focusing on the trade (distributors, exchanges etc…). Producers raised on average $2 million per deal which is slightly higher than companies in associated activities. It certainly seems professional smart money is putting some skin in the game based on the categories’ leaders.
On the producer side, Mettrum, a Health Canada licensed producer of medicinal cannabis, lead the pack placing $4.2 million with US investors. The company initiated a reverse take-over in June to list on TSX Venture and completed the transaction two days ago. The company raised gross proceeds of $34.5 million from the private placement which was completed by a syndicate of agents led by Cormark Securities and including GMP Securities, Paradigm Capital and Jacob Securities.
In the other category, Privateer Holdings placed $18.7 million. Privateer is a private equity firm making strategic investments in the cannabis industry to acquire and create mainstream brands, professionalizing the cannabis business landscape. The company is backed by Ivy League MBAs, marketing professionals, and federal law enforcement professionals. The company is currently invested in Tilray (a premium brand of medical cannabis) and Leafly (an online information resource for cannabis consumers).
|Royale Leisure Industries||1||1,000,000||500,000|
|Phoenix Pharms Capital||1||2,500,000||126,000|
|Colorado Cannabis Exchange||1||100,000||10,000|
|Green Star Growing||1||5,000,000||950,000|
|Waveseer of Las Vegas||1||8,730,000||200,000|
|Pure Natures Wellness||1||40,549||40,549|
*offered by US based companies or to US based investors. If the company is located outside the US only the portion of the placement allocated to US investors is taken into account.